First European randomized trial confirms new pneumococcal vaccine highly effective in infants
A new conjugate vaccine is highly effective (93%) at preventing invasive pneumococcal disease (IPD; meningitis, sepsis, bacteremic pneumonia, and other blood-borne infections) in infants younger than 2 years who are the most ...
Nov 15, 2012
0
0